Edward Christopher Dee

Research Interests: prostate cancer clinical research; gastrointestinal tumors; radiation oncology; ablative radiation; cancer disparities in the US and Asia; financial toxicity of cancer care

Biography: Chris is from Manila, Philippines, and Vancouver, Canada. He studied molecular biophysics and biochemistry at Yale and completed his medical degree at Harvard. He is in radiation oncology residency at Memorial Sloan Kettering Cancer Center. His primary research is with the Dana Farber Cancer Institute genitourinary radiation oncology group, mentored by Dr. Paul Nguyen and Dr. Anthony D'Amico. At Massachusetts General Hospital, he worked with the group of Dr. Ted Hong and Dr. Jennifer Wo studying cholangiocarcinoma. At MSK, he works with Dr. Fumiko Chino and Dr. Chris Crane. 
Chris also works closely with academics and physicians in the Philippines and was listed in Forbes Asia 30 Under 30 for Healthcare and Sciences in 2021. 

Websitehttps://scholar.google.com/citations?user=EPLEf60AAAAJ&hl=en&oi=ao

Selected publications:
Dee EC, Muralidhar V, King MT, Martin NE, D’Amico AV, Mouw KW, Orio PF, Nguyen PL, Leeman JE. Second malignancy probabilities in prostate cancer patients treated with SBRT and other contemporary radiation techniques. Radiotherapy and Oncology accepted 15 June 2021. 

Dee EC, Paguio JA, Yao JS, Lim J, Lasco G. Asian Minorities in Asian Countries: the need to assess and address intersecting disparities affecting minoritized groups. Lancet Oncology accepted 10 June 2021. 

Dee EC, Byrne JD, Wo JW. Evolution of the role of radiotherapy for anal cancer. Cancers accepted 6 March 2021. 

Dee EC, Arega MA, Yang DD, Butler SS, Mahal BA, Sanford NN, Nguyen PL, Muralidhar V. Disparities in Refusal of Locoregional Treatment for Prostate Adenocarcinoma. JCO Oncology Practice accepted 26 January 2021. 

Dee EC, Muralidhar V, Arega MA, Kishan AU, Spratt DE, Dess RT, King MT, Sha ST, Santos PMG, Butler SS, Sanford NN, Nguyen PL, Mahal BA. Factors influencing non-completion of radiotherapy among men with localized prostate cancer. International Journal of Radiation Oncology • Biology • Physics (IJROBP) accepted 25 November 2020. 

Dee EC, Mahal BA, Arega MA, D’Amico AV, Mouw KW, Nguyen PL, Muralidhar V. Timing of Radiation and Androgen Deprivation for Prostate Cancer: Implications for Treatment during the COVID-19 Pandemic. JAMA Oncology accepted 18 June 2020. 

Dee EC, Freret ME, Horick N, Raldow AC, Goyal L, Zhu AX, Parikh AR, Ryan DP, Clark JW, Allen JN, Ferrone CR, Fernandez-del Castillo C, Tanabe KK, Drapek LC, Hong TS, Qadan M, Wo JY. Patterns of failure and need for biliary intervention in resected biliary tract cancers after chemoradiation. Annals of Surgical Oncology (ASO), accepted 10 June 2020.